Financial Architects (New Jersey)’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-385
Closed -$46K – 882
2019
Q4
$46K Sell
385
-1,130
-75% -$126K 0.01% 444
2019
Q3
$151K Sell
1,515
-2,917
-66% -$305K 0.04% 270
2019
Q2
$484K Buy
4,432
+412
+10% +$43.8K 0.09% 150
2019
Q1
$449K Buy
+4,020
New +$441K 0.08% 179
2018
Q4
– Sell
-1,400
Closed -$149K – 1400
2018
Q3
$171K Buy
1,400
+500
+56% +$58.9K 0.03% 341
2018
Q2
$99K Hold
900
– – 0.02% 407
2018
Q1
$96K Sell
900
-1,515
-63% -$168K 0.02% 462
2017
Q4
$258K Sell
2,415
-90
-4% -$9.62K 0.04% 280
2017
Q3
$279K Buy
2,505
+213
+9% +$22.8K 0.05% 251
2017
Q2
$237K Buy
2,292
+1,062
+86% +$105K 0.04% 281
2017
Q1
$120K Hold
1,230
– – 0.02% 420
2016
Q4
$109K Hold
1,230
– – 0.03% 378
2016
Q3
$119K Hold
1,230
– – 0.03% 357
2016
Q2
$106K Buy
1,230
+330
+37% +$29.6K 0.03% 362
2016
Q1
$78K Buy
+900
New +$80.5K 0.03% 329
2015
Q3
– Sell
-2,580
Closed -$317K – 528
2015
Q2
$317K Hold
2,580
– – 0.11% 137
2015
Q1
$295K Buy
2,580
+1,980
+330% +$218K 0.11% 140
2014
Q4
$61K Buy
600
+300
+100% +$29.2K 0.03% 318
2014
Q3
$27K Hold
300
– – 0.01% 412
2014
Q2
$26K Buy
+300
New +$23.6K 0.01% 442
2013
Q4
– Sell
-300
Closed -$21K – 338
2013
Q3
$21K Hold
300
– – 0.01% 383
2013
Q2
$17K Buy
+300
New +$17.3K 0.01% 386

Other funds holding IBB

Financial Architects (New Jersey)'s IBB Position: Q1 2020 in Review

Financial Architects (New Jersey) sold out of iShares Biotechnology ETF (IBB) in Q1 2020, closing a stake of 385 shares — an estimated $46K sold.

Financial Architects (New Jersey) first reported a position in IBB in Q2 2013 and held it in 22 quarters. The position peaked at $484K in Q2 2019. 666 funds tracked by Wall St. Rank hold IBB as of Q1 2020.

  • Financial Architects (New Jersey) reported no remaining iShares Biotechnology ETF position as of Q1 2020 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 385 iShares Biotechnology ETF shares in Q1 2020, an estimated $46K.
  • Financial Architects (New Jersey) first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 22 quarters.
  • Financial Architects (New Jersey)'s iShares Biotechnology ETF position peaked at $484K in Q2 2019.
  • 666 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2020, filed 7 May 2020.